Pettersson B - Search Results

1

Self-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (Exhype).

Pettersson B, Rosenqvist U, Deleskog A, Journath G, Wändell P. Pettersson B, et al. Diabetes Res Clin Pract. 2011 Apr;92(1):19-25. doi: 10.1016/j.diabres.2010.12.005. Epub 2010 Dec 30. Diabetes Res Clin Pract. 2011. PMID: 21195501

2

Utilization and costs of glucose lowering therapies following health technology assessment for the new reimbursement scheme in Sweden.

Pettersson B, Hoffmann M, Andersson D, Wändell P, Levin LÅ. Pettersson B, et al. Health Policy. 2012 Dec;108(2-3):207-15. doi: 10.1016/j.healthpol.2012.10.008. Epub 2012 Nov 8. Health Policy. 2012. PMID: 23140907

3

Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes.

Walz L, Pettersson B, Rosenqvist U, Deleskog A, Journath G, Wändell P. Walz L, et al. Among authors: pettersson b. Patient Prefer Adherence. 2014 Apr 30;8:593-601. doi: 10.2147/PPA.S58781. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 24812495 Free PMC article.

4

Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA).

Pettersson B, Ambegaonkar B, Sazonov V, Martinell M, Stålhammar J, Wändell P. Pettersson B, et al. BMC Public Health. 2010 Nov 29;10:737. doi: 10.1186/1471-2458-10-737. BMC Public Health. 2010. PMID: 21114824 Free PMC article.

5

Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden.

Pettersson B, Hoffmann M, Wändell P, Levin LÅ. Pettersson B, et al. Health Policy. 2012 Jan;104(1):84-91. doi: 10.1016/j.healthpol.2011.10.010. Epub 2011 Nov 23. Health Policy. 2012. PMID: 22115548

6

Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline.

Journath G, Hambraeus K, Hagström E, Pettersson B, Löthgren M. Journath G, et al. Among authors: pettersson b. BMC Cardiovasc Disord. 2017 Aug 16;17(1):224. doi: 10.1186/s12872-017-0659-2. BMC Cardiovasc Disord. 2017. PMID: 28814290 Free PMC article.

7

[Important to keep the principle of value-based pricing of drugs].

Persson U, Levin LA, Pettersson B. Persson U, et al. Among authors: pettersson b. Lakartidningen. 2009 Oct 28-Nov 3;106(44):2862-4. Lakartidningen. 2009. PMID: 19967967 Swedish. No abstract available.

8

A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing.

Persson U, Svensson J, Pettersson B. Persson U, et al. Among authors: pettersson b. Appl Health Econ Health Policy. 2012 Jul 1;10(4):217-25. doi: 10.2165/11633930-000000000-00000. Appl Health Econ Health Policy. 2012. PMID: 22676213

9

Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.

Ambegaonkar BM, Bash LD, Chirovsky DR, Jameson K, Grant S, Nocea G, Pettersson B, Sazonov V. Ambegaonkar BM, et al. Among authors: pettersson b. Eur J Intern Med. 2013 Oct;24(7):656-63. doi: 10.1016/j.ejim.2013.07.005. Epub 2013 Aug 13. Eur J Intern Med. 2013. PMID: 23953848

10

Authors' reply to Godman and Gustafsson: "A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing".

Persson U, Svensson J, Pettersson B. Persson U, et al. Among authors: pettersson b. Appl Health Econ Health Policy. 2013 Feb;11(1):83-4. doi: 10.1007/s40258-013-0009-1. Appl Health Econ Health Policy. 2013. PMID: 23359036 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters